China's SOEs Sustain R&D Spending Over 1 Trillion Yuan for Four Years

In 2025, China's state-owned enterprises (SOEs) under central government supervision invested 1.1 trillion yuan, roughly equivalent to 157.69 billion U.S. dollars, in research and development (R&D). This substantial investment underscores a commitment to advancing technology and innovation.
According to Pang Xiaogang, deputy head of the State-owned Assets Supervision and Administration Commission of the State Council, this continuous R&D expenditure has remained above the critical threshold of 1 trillion yuan for four consecutive years.
Central SOEs have played an essential role in promoting key technologies and nurturing strategic emerging industries. Their efforts are vital for developing new, high-quality productive forces that are pivotal for China's future economic landscape.
Additionally, in 2025, these state-owned entities earmarked 2.5 trillion yuan, approximately 359.5 billion U.S. dollars, towards strategic emerging industries, signifying 41.8 percent of their total investment. Such substantial financial commitments catalyze growth across both upstream and downstream sectors within industrial chains.
This strategic focus on emerging industries has not only enhanced economic resilience but also provided robust support for the overall social and economic development of the nation.
The latest data indicates that central SOEs achieved a total profit of 2.5 trillion yuan in 2025. Furthermore, total assets held by these enterprises exceeded 95 trillion yuan, or about 13.7 trillion U.S. dollars, by the end of the previous year.
The performance of these enterprises reflects their crucial role in supporting China's ambitions in science and technology, contributing to the nation's standing as a global economic powerhouse.
As China continues to prioritize self-reliance and innovation, the commitment of central SOEs to R&D and strategic investments will remain vital in achieving long-term goals for economic development.
Read These Next

Risks of Trusting AI Chatbots for Medical Advice
This article explores the accuracy and reliability of AI chatbots in providing medical advice, highlighting findings from a University of Oxford study that indicate inconsistencies and the potential risks of relying on such technologies for healthcare.

TCM Achieves Major Inheritance and Innovation Breakthroughs in 2025
In 2025, China advanced Traditional Chinese Medicine with 90 new departments and 212 clinical projects, enhancing modernization efforts.

Qinling Station Highlights China's Innovative Green Polar Tech
China's 42nd Antarctic expedition completed a rotation at Qinling Station, operational since Feb 7, 2024, boasting 60% renewable energy.
